A citation-based method for searching scientific literature

Anne L Peters, Robert R Henry, Payal Thakkar, Cindy Tong, Maria Alba. Diabetes Care 2016
Times Cited: 57

Julia Hine, Heather Paterson, Esha Abrol, David Russell-Jones, Roselle Herring. Lancet Diabetes Endocrinol 2015
Times Cited: 54

List of shared articles

Times cited

SGLT2 inhibitors in Type 1 diabetes: is this the future?
R Herring, D L Russell-Jones. Diabet Med 2018

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis.
Xiaofang Yu, Saifei Zhang, Long Zhang. Int J Endocrinol 2018

SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-Fran├žois Yale. Clin Ther 2016

Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.
Yiting Wang, Mehul Desai, Patrick B Ryan, Frank J DeFalco, Martijn J Schuemie, Paul E Stang, Jesse A Berlin, Zhong Yuan. Diabetes Res Clin Pract 2017

Canagliflozin-Induced Diabetic Ketoacidosis: Case Report and Review of the Literature.
Jessica Turner, Tahmina Begum, Roger D Smalligan. J Investig Med High Impact Case Rep 2016

SGLT inhibition: a possible adjunctive treatment for type 1 diabetes.
Halis Kaan Akturk, Amanda Rewers, Satish K Garg. Curr Opin Endocrinol Diabetes Obes 2018